Improved Diabetes Care Products Offer Hope for Children and Their Families
FocusPharmacy.com Pens Agreement with Diabetes Sentry Products


    /Pharmaceutical News Articles/ - Doylestown, PA, August 03, 2008 - Focus Express Mail Pharmacy, a leading on-line pharmacy specializing in diabetes care, announced a renewed distribution agreement with Diabetes Sentry Products, Inc., a life-saving portable device manufacturer, to continue to help children and their families manage the complications of diabetes. FocusPharmacy.com will feature Diabetes Sentry's newly FDA approved product, the Sleep Sentry, which alerts people with diabetes of impending medical complications associated with diabetes.

Type 1 diabetes, a rapidly progressive disease which currently affects 2 million children nationwide, is steadily rising among young children and adults. Little or no insulin, a hormone necessary to convert food into energy, is produced in the pancreas in a person with Type 1 diabetes.

Research conducted on Type 1 diabetes shows that the mortality rate of patients with insulin-dependent diabetes increases dramatically after 15 years of suffering with the disease. With the cost of healthcare rising, many diabetes sufferers are now cutting back on their medications, increasing their chances of developing additional and potentially fatal medical complications. To date, diabetes is the sixth leading cause of death by disease in the United States, killing close to 200,000 people each year and roughly 665,000 new cases of diabetes are diagnosed annually with recent trends showing no signs of stopping.

"Although more has to be done to diagnose diabetes in children in a timely manner and give them adequate care, rising health care costs coupled with caring for a young child proves to be a tough challenge for many caretakers", says Joel Shpigel, R.Ph., CEO and Co-founder of Focus Express Mail Pharmacy. "It is important to Focus Express Mail Pharmacy to provide patients and caretakers with this life-saving technology that while necessary is affordable and can ease some of the difficulties of managing diabetes."

Diabetes Sentry re-released the Sleep Sentry, a portable device worn around the wrist at night to monitor the temperature and moisture of the skin while sleeping. If a hypoglycemic reaction occurs during sleep, the skin will get cold and moist (cold sweat) setting off the Sleep Sentry alarm and waking the patient. Hypoglycemia affects most, if not all, people with Type 1 diabetes and can become a medical emergency if not treated in a timely manner. It can lead to a prolonged unconscious state, permanent brain damage, or even death. Some research estimates that between 4 and 13 percent of the deaths of people with type I diabetes results from hypoglycemic events. This new FDA approved model provides monitoring that people with diabetes need while sleeping.

Further Related Resources:


Press Release Contact Information:

Marisa Veni
Furia Rubel Communications
Public Relations Coordinator
2 Hidden Lane
Doylestown, PA
USA 18901
Voice: 215-340-0480
Fax: 215-340-0580
Website: Visit Our Website